Xilis

About

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Durham,North Carolina,United States
51 - 100
http://www.xilis.net/

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $19M
Industries: Biotechnology,Health Care,Health Diagnostics,Life Science,Pharmaceutical
Founded date: Jan 1, 2019
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Xilis Inc.

Xilis is an oncology and precision health company that diagnoses cancer and finds the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster.

It was founded in 2019 and is headquartered in Durham, North Carolina.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$92M

Xilis has raised a total of $92M in funding over 2 rounds. Their latest funding was raised on Jul 13, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 13, 2022	Series A	$19M	11	FPV Ventures	—	Detail
Jul 8, 2021	Series A	$70M	10	Mubadala Capital Ventures	—	Detail
May 5, 2020	Seed	—	3	Two Sigma Ventures	—	Detail
Dec 10, 2019	Seed	$3M	4	Felicis Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

15

Xilis is funded by 15 investors. FPV Ventures and Alexandria Venture Investments are the most recent investors.

Investor Name	Lead Investor	Funding Round
FPV Ventures	Yes	Series A
Alexandria Venture Investments	—	Series A
Alix Ventures	—	Series A
Catalio Capital Management	—	Series A
Duke Angel Network	—	Series A
EQT AB	—	Series A
Felicis Ventures	—	Series A
GV	—	Series A
Mubadala Capital Ventures	—	Series A
Pear VC	—	Series A